Topical steroid withdrawal syndrome: time to bridge the gap
- PMID: 35833942
- DOI: 10.1111/bjd.21770
Topical steroid withdrawal syndrome: time to bridge the gap
Comment in
-
Potency of topical steroids should be clearly labelled on all packaging.Br J Dermatol. 2023 Feb 22;188(3):427-428. doi: 10.1093/bjd/ljac104. Br J Dermatol. 2023. PMID: 36637151 No abstract available.
References
-
- NHS Business Services Authority. NHSBSA Statistics and Data Science. Prescription Cost Analysis - England 2020/21. Available at: nhsbsa.nhs.uk/statistical-collections/prescription-cost-analysis-england... (last accessed 20 July 2022).
-
- Medicines and Healthcare products Regulatory Agency Press release. Long-term continual use of topical steroids linked to skin withdrawal side effects. Available at: https://www.gov.uk/government/news/long-term-continual-use-of-topical-st... (last accessed 20 July 2022).
-
- Hwang J, Lio PA. Topical corticosteroid withdrawal (‘steroid addiction’): an update of a systematic review. J Dermatolog Treat 2022; 33:1293-8.
-
- Bowe S, Masterson S, Murray G, Haugh I. Topical steroid withdrawal through the lens of social media. Clin Exp Dermatol 2022; 47:1554-7.
-
- National Eczema Society and British Association of Dermatologists joint position statement on topical steroid withdrawal. January 2021. Available at: eczema.org/wp-content/uploads/Topical-Steroid-Withdrawal-position-statem... (last accessed 20 July 2022).
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous